Showing results (1001-1010 of 1,105) with videos related to
Sort By:
Pageof 111
BMC Geriatrics|October 18, 2017
Feasibility of a multi-modal exercise program on cognition in older adults with Type 2 diabetes - a pilot randomised controlled trialM L Callisaya, R M Daly, J E Sharman, et al.Proceedings of the National Academy of Sciences of the United States of America|August 16, 2011
Regenerative phenotype in mice with a point mutation in transforming growth factor beta type I receptor (TGFBR1)Jun Liu, Kristen Johnson, Jie Li, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2010
Combination therapy targeting both tumor-initiating and differentiated cell populations in prostate carcinomaAnna Dubrovska, Jimmy Elliott, Richard J Salamone, et al.Ecology and Evolution|September 3, 2025
Consequences of Cancer on Zebrafish Danio rerio: Insights Into Sex Determination, Sex Ratio, and Offspring SurvivalJustine Boutry, Mathieu Douhard, Klara Asselin, et al.Nature|October 17, 2018
A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signallingMichael J Bollong, Gihoon Lee, John S Coukos, et al.Bioconjugate Chemistry|May 7, 2015
Targeted Delivery of LXR Agonist Using a Site-Specific Antibody-Drug ConjugateReyna K V Lim, Shan Yu, Bo Cheng, et al.Angewandte Chemie (International Ed. in English)|September 7, 2016
Multifunctional Antibody Agonists Targeting Glucagon-like Peptide-1, Glucagon, and Glucose-Dependent Insulinotropic Polypeptide ReceptorsYing Wang, Jintang Du, Huafei Zou, et al.Hypertension (Dallas, Tex. : 1979)|April 11, 2020
Nonvalidated Home Blood Pressure Devices Dominate the Online Marketplace in Australia: Major Implications for Cardiovascular Risk ManagementDean S Picone, Rewati A Deshpande, Martin G Schultz, et al.Journal of Medicinal Chemistry|December 14, 2001
Synthesis and biological evaluation of myoseverin derivatives: microtubule assembly inhibitorsY T Chang, S M Wignall, G R Rosania, et al.Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
A genomic screen identifies TYRO3 as a MITF regulator in melanomaShoutian Zhu, Heiko Wurdak, Yan Wang, et al.Pageof 111